Target Gene/Pathway Pathway / Gene

---

Search results

---

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	Adipocytokine signaling pathway 💬	[1] NR1C1 💬 Adipocytokine signaling pathway × Name Full Name NR1C1	Bezafibrate 💬 Adipocytokine signaling pathway × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 1. Adipocytokine signaling pathway × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
2	Adrenergic signaling in cardiomyocytes 💬	[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Noradrenaline 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 2. Adrenergic signaling in cardiomyocytes × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
3	Adrenergic signaling in cardiomyocytes 💬	[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Norepinephrine bitartrate 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 2. Adrenergic signaling in cardiomyocytes × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
4	Adrenergic signaling in cardiomyocytes 💬	[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Norepinephrine hydrochoride 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 2. Adrenergic signaling in cardiomyocytes × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
5	Adrenergic signaling in cardiomyocytes 💬	[2] ADRB1, ADRB2 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Propranolol hydrochloride 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 5. Adrenergic signaling in cardiomyocytes × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
6	Adrenergic signaling in cardiomyocytes 💬	[2] ADRB1, ADRB2 💬 Adrenergic signaling in cardiomyocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Propranolol 💬 Adrenergic signaling in cardiomyocytes × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 5. Adrenergic signaling in cardiomyocytes × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
7	Alcoholic liver disease 💬	[1] NR1C1 💬 Alcoholic liver disease × Name Full Name NR1C1	Bezafibrate 💬 Alcoholic liver disease × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 7. Alcoholic liver disease × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
8	Alzheimer disease 💬	[4] CHRM1, CHRM3, CHRM5, CHRNA7 💬 Alzheimer disease × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM3 cholinergic receptor muscarinic 3 CHRM5 cholinergic receptor muscarinic 5 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit	Rocuronium bromide 💬 Alzheimer disease × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 8. Alzheimer disease × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
9	Alzheimer disease 💬	[1] PTGS2 💬 Alzheimer disease × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Alzheimer disease × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 9. Alzheimer disease × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
10	AMPK signaling pathway 💬	[1] ADRA1A 💬 AMPK signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A	Noradrenaline 💬 AMPK signaling pathway × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 10. AMPK signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
11	AMPK signaling pathway 💬	[1] ADRA1A 💬 AMPK signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A	Norepinephrine bitartrate 💬 AMPK signaling pathway × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 10. AMPK signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
12	AMPK signaling pathway 💬	[1] ADRA1A 💬 AMPK signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A	Norepinephrine hydrochoride 💬 AMPK signaling pathway × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 10. AMPK signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
13	Arachidonic acid metabolism 💬	[1] PTGS2 💬 Arachidonic acid metabolism × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Arachidonic acid metabolism × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 13. Arachidonic acid metabolism × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
14	Bile secretion 💬	[1] NR1H4 💬 Bile secretion × Name Full Name NR1H4 nuclear receptor subfamily 1 group H member 4	Obeticholic acid 💬 Bile secretion × Name Other Names Obeticholic acid Obeticholic acid (JAN/USAN/INN) Ocaliva (TN) OCALIVA	Obeticholic acid	[3] 93, 265, 296 💬 14. Bile secretion × Disease ID Name 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 265 Lipodystrophy; 296 Biliary atresia;
15	Bile secretion 💬	[1] NR1H4 💬 Bile secretion × Name Full Name NR1H4 nuclear receptor subfamily 1 group H member 4	Ursodiol 💬 Bile secretion × Name Other Names Ursodiol Ursodiol (USP) Ursodeoxycholic acid (JP18/INN) Actigall (TN) Urso (TN) URSODIOL USODIOL	Ursodeoxycholic acid	[14]  6 ,  8 , 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬 15. Bile secretion × Disease ID Name  6  Parkinson disease;Disease Parkinson's;  8  Huntington disease;Huntington chorea; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 67 Polycystic kidney disease;PKD;PCKD;Polycystic kidney;Autosomal dominant PKD;ADPKD;Autosomal recessive PKD;ARPKD; 84 Sarcoidosis; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 234 Peroxisomal disease (except Adrenoleukodystrophy);Peroxisomal disease;Peroxisomal disorder;Peroxisome biogenesis disorder;Contiguous ABCD1/DXS1357E deletion syndrome;CADDS;Peroxisome biogenesis disorder;PBD;PEX gene disorder;Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease;Rhizomelic chondrodysplasia punctata type 1;RCDP type 1;RCDP1;Peroxisomal beta-oxidation enzyme deficiency;Acyl-CoA oxidase deficiency;AOX deficiency;D-Bifunctional protein deficiency;DBP deficiency;Sterol carrier protein X deficiency;SCPx deficiency;2-methylacyl-CoA racemase deficiency;Alpha-methylacyl-CoA racemase deficiency;AMACR deficiency;Plasmalogen biosynthesis enzyme deficiency;Rhizomelic chondrodysplasia punctata type 2;RCDP type 2;RCDP2;Rhizomelic chondrodysplasia punctata type 3;RCDP type 3;RCDP3;Refsum disease;Primary hyperoxaluria type 1;PH1;Primary hyperoxaluria;Acatalasemia;Acatalasia;Takahara disease; 296 Biliary atresia; 299 Cystic fibrosis;CF;
16	Bile secretion 💬	[2] SLC10A1, SLC10A2 💬 Bile secretion × Name Full Name SLC10A1 solute carrier family 10 member 1 SLC10A2 solute carrier family 10 member 2	Maralixibat 💬 Bile secretion × Name Other Names Maralixibat Maralixibat (USAN)	Maralixibat	[4] 296, 297, 299, 338 💬 16. Bile secretion × Disease ID Name 296 Biliary atresia; 297 Alagille syndrome; 299 Cystic fibrosis;CF; 338 Progressive familial intrahepatic cholestasis;PFIC;
17	Bile secretion 💬	[1] SLC10A2 💬 Bile secretion × Name Full Name SLC10A2 solute carrier family 10 member 2	Maralixibat chloride 💬 Bile secretion × Name Other Names Maralixibat chloride Maralixibat chloride (JAN/USAN/INN) Livmarli (TN) LIVMARLI	Maralixibat	[4] 296, 297, 299, 338 💬 17. Bile secretion × Disease ID Name 296 Biliary atresia; 297 Alagille syndrome; 299 Cystic fibrosis;CF; 338 Progressive familial intrahepatic cholestasis;PFIC;
18	Bile secretion 💬	[1] SLC10A2 💬 Bile secretion × Name Full Name SLC10A2 solute carrier family 10 member 2	Odevixibat 💬 Bile secretion × Name Other Names Odevixibat Odevixibat (USAN)	Odevixibat	[3] 296, 297, 338 💬 18. Bile secretion × Disease ID Name 296 Biliary atresia; 297 Alagille syndrome; 338 Progressive familial intrahepatic cholestasis;PFIC;
19	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬 C-type lectin receptor signaling pathway × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 C-type lectin receptor signaling pathway × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 19. C-type lectin receptor signaling pathway × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
20	Calcium signaling pathway 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 Calcium signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Calcium signaling pathway × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 20. Calcium signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
21	Calcium signaling pathway 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 Calcium signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Calcium signaling pathway × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 20. Calcium signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
22	Calcium signaling pathway 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 Calcium signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Calcium signaling pathway × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 20. Calcium signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
23	Calcium signaling pathway 💬	[3] ADRB1, ADRB2, ADRB3 💬 Calcium signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Calcium signaling pathway × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 23. Calcium signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
24	Calcium signaling pathway 💬	[3] ADRB1, ADRB2, ADRB3 💬 Calcium signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Calcium signaling pathway × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 23. Calcium signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
25	Calcium signaling pathway 💬	[5] CHRM1, CHRM2, CHRM3, CHRM5, CHRNA7 💬 Calcium signaling pathway × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2 CHRM3 cholinergic receptor muscarinic 3 CHRM5 cholinergic receptor muscarinic 5 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit	Rocuronium bromide 💬 Calcium signaling pathway × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 25. Calcium signaling pathway × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
26	cAMP signaling pathway 💬	[2] ADRB1, ADRB2 💬 cAMP signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Noradrenaline 💬 cAMP signaling pathway × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 26. cAMP signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
27	cAMP signaling pathway 💬	[2] ADRB1, ADRB2 💬 cAMP signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Norepinephrine bitartrate 💬 cAMP signaling pathway × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 26. cAMP signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
28	cAMP signaling pathway 💬	[2] ADRB1, ADRB2 💬 cAMP signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Norepinephrine hydrochoride 💬 cAMP signaling pathway × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 26. cAMP signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
29	cAMP signaling pathway 💬	[2] ADRB1, ADRB2 💬 cAMP signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Propranolol hydrochloride 💬 cAMP signaling pathway × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 29. cAMP signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
30	cAMP signaling pathway 💬	[2] ADRB1, ADRB2 💬 cAMP signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Propranolol 💬 cAMP signaling pathway × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 29. cAMP signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
31	cAMP signaling pathway 💬	[2] CHRM1, CHRM2 💬 cAMP signaling pathway × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2	Rocuronium bromide 💬 cAMP signaling pathway × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 31. cAMP signaling pathway × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
32	cAMP signaling pathway 💬	[1] NR1C1 💬 cAMP signaling pathway × Name Full Name NR1C1	Bezafibrate 💬 cAMP signaling pathway × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 32. cAMP signaling pathway × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
33	cGMP-PKG signaling pathway 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 cGMP-PKG signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 cGMP-PKG signaling pathway × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 33. cGMP-PKG signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
34	cGMP-PKG signaling pathway 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 cGMP-PKG signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 cGMP-PKG signaling pathway × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 33. cGMP-PKG signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
35	cGMP-PKG signaling pathway 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 cGMP-PKG signaling pathway × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 cGMP-PKG signaling pathway × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 33. cGMP-PKG signaling pathway × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
36	cGMP-PKG signaling pathway 💬	[3] ADRB1, ADRB2, ADRB3 💬 cGMP-PKG signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 cGMP-PKG signaling pathway × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 36. cGMP-PKG signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
37	cGMP-PKG signaling pathway 💬	[3] ADRB1, ADRB2, ADRB3 💬 cGMP-PKG signaling pathway × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 cGMP-PKG signaling pathway × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 36. cGMP-PKG signaling pathway × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
38	Chemical carcinogenesis - DNA adducts 💬	[1] PTGS2 💬 Chemical carcinogenesis - DNA adducts × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Chemical carcinogenesis - DNA adducts × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 38. Chemical carcinogenesis - DNA adducts × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
39	Chemical carcinogenesis - reactive oxygen species 💬	[1] KLHL19 💬 Chemical carcinogenesis - reactive oxygen species × Name Full Name KLHL19	Dimethyl fumarate 💬 Chemical carcinogenesis - reactive oxygen species × Name Other Names Dimethyl fumarate Dimethyl fumarate (JAN/USAN) Tecfidera (TN) TECFIDERA DIMETHYL FUMARATE	Dimethyl fumarate	[6] 13, 20, 49, 51, 86, 296 💬 39. Chemical carcinogenesis - reactive oxygen species × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH; 296 Biliary atresia;
40	Chemical carcinogenesis - receptor activation 💬	[3] ADRB1, ADRB2, ADRB3 💬 Chemical carcinogenesis - receptor activation × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Chemical carcinogenesis - receptor activation × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 40. Chemical carcinogenesis - receptor activation × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
41	Chemical carcinogenesis - receptor activation 💬	[3] ADRB1, ADRB2, ADRB3 💬 Chemical carcinogenesis - receptor activation × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Chemical carcinogenesis - receptor activation × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 40. Chemical carcinogenesis - receptor activation × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
42	Chemical carcinogenesis - receptor activation 💬	[3] ADRB1, ADRB2, ADRB3 💬 Chemical carcinogenesis - receptor activation × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Chemical carcinogenesis - receptor activation × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 40. Chemical carcinogenesis - receptor activation × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
43	Chemical carcinogenesis - receptor activation 💬	[3] ADRB1, ADRB2, ADRB3 💬 Chemical carcinogenesis - receptor activation × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Chemical carcinogenesis - receptor activation × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 43. Chemical carcinogenesis - receptor activation × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
44	Chemical carcinogenesis - receptor activation 💬	[3] ADRB1, ADRB2, ADRB3 💬 Chemical carcinogenesis - receptor activation × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Chemical carcinogenesis - receptor activation × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 43. Chemical carcinogenesis - receptor activation × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
45	Chemical carcinogenesis - receptor activation 💬	[6] CHRNA3, CHRNA4, CHRNA7, CHRNA9, CHRNB2, CHRNB4 💬 Chemical carcinogenesis - receptor activation × Name Full Name CHRNA3 cholinergic receptor nicotinic alpha 3 subunit CHRNA4 cholinergic receptor nicotinic alpha 4 subunit CHRNA7 cholinergic receptor nicotinic alpha 7 subunit CHRNA9 cholinergic receptor nicotinic alpha 9 subunit CHRNB2 cholinergic receptor nicotinic beta 2 subunit CHRNB4 cholinergic receptor nicotinic beta 4 subunit	Rocuronium bromide 💬 Chemical carcinogenesis - receptor activation × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 45. Chemical carcinogenesis - receptor activation × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
46	Chemical carcinogenesis - receptor activation 💬	[1] NR1C1 💬 Chemical carcinogenesis - receptor activation × Name Full Name NR1C1	Bezafibrate 💬 Chemical carcinogenesis - receptor activation × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 46. Chemical carcinogenesis - receptor activation × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
47	Cholinergic synapse 💬	[11] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4 💬 Cholinergic synapse × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2 CHRM3 cholinergic receptor muscarinic 3 CHRM4 cholinergic receptor muscarinic 4 CHRM5 cholinergic receptor muscarinic 5 CHRNA3 cholinergic receptor nicotinic alpha 3 subunit CHRNA4 cholinergic receptor nicotinic alpha 4 subunit CHRNA6 cholinergic receptor nicotinic alpha 6 subunit CHRNA7 cholinergic receptor nicotinic alpha 7 subunit CHRNB2 cholinergic receptor nicotinic beta 2 subunit CHRNB4 cholinergic receptor nicotinic beta 4 subunit	Rocuronium bromide 💬 Cholinergic synapse × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 47. Cholinergic synapse × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
48	Cytokine-cytokine receptor interaction 💬	[1] CSF3R 💬 Cytokine-cytokine receptor interaction × Name Full Name CSF3R colony stimulating factor 3 receptor	Filgrastim 💬 Cytokine-cytokine receptor interaction × Name Other Names Filgrastim Filgrastim (USP/INN) Filgrastim (genetical recombination) (JP18) Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN) Tbo-filgrastim Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN) Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN) Filgrastim-sndz Filgrastim-aafi Neupogen (TN) Nivestym (TN) Grastofil (TN) Zarxio (TN) GRANIX NEUPOGEN NIVESTYM NYPOZI RELEUKO ZARXIO	Filgrastim	[29]  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 48. Cytokine-cytokine receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 47 Buerger disease;Thromboangiitis obliterans; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 256 Muscle glycogenosis;Muscular glycogenosis;Muscle glycogen storage disease;Muscular glycogen storage disease;Glycogen storage disease type 0;GSD0;Glycogen synthase deficiency;Glycogen storage disease type II;GSDII;Pompe disease;Alpha-1,4-glucosidase acid deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Glycogen storage disease type V;GSDV;McArdle disease;Muscle phosphorylase deficiency;Muscular phosphorylase deficiency;Glycogen storage disease type VII;GSDVII;Tarui disease;Phosphofructokinase deficiency;PFK deficiency;Glycogen storage disease type IXd;GSDIXd;Phosphorylase kinase deficiency;Phosphoglycerate kinase deficiency;PGK deficiency;Glycogen storage disease type X;GSDX;Phosphoglycerate mutase deficiency;Glycogen storage diseass type XI;GSDXI;Kanno disease;Lactate dehydrogenase deficiency;Glycogen storage diseass type XII;GSDXII;Aldolase A deficiency;Glycogen storage diseass type XIII;GSDXIII;Beta-enolase deficiency;Glycogen storage diseass type XIV;GSDXIV;Phosphoglucomutase deficiency;Glycogen storage diseass type XV;GSDXV;Glycogenin 1 deficiency; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
49	Cytokine-cytokine receptor interaction 💬	[1] TNFSF13B 💬 Cytokine-cytokine receptor interaction × Name Full Name TNFSF13B TNF superfamily member 13b	Belimumab 💬 Cytokine-cytokine receptor interaction × Name Other Names Belimumab Belimumab (USAN) Belimumab (genetical recombination) (JAN) Benlysta (TN) LymphoStat-B (TN) BENLYSTA	Belimumab	[14] 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬 49. Cytokine-cytokine receptor interaction × Disease ID Name 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 43 Microscopic polyangiitis;MPA; 44 Wegener granulomatosis;Multiple vasculitis granulomatous disease;Granulomatosis with polyangiitis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 48 Primary antiphospholipid syndrome;Primary antiphospholipid antibody syndrome;Primary APS;PAPS; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 95 Autoimmune hepatitis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 296 Biliary atresia;
50	Diabetic cardiomyopathy 💬	[1] NR1C1 💬 Diabetic cardiomyopathy × Name Full Name NR1C1	Bezafibrate 💬 Diabetic cardiomyopathy × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 50. Diabetic cardiomyopathy × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
51	Dilated cardiomyopathy 💬	[1] ADRB1 💬 Dilated cardiomyopathy × Name Full Name ADRB1 adrenoceptor beta 1	Noradrenaline 💬 Dilated cardiomyopathy × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 51. Dilated cardiomyopathy × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
52	Dilated cardiomyopathy 💬	[1] ADRB1 💬 Dilated cardiomyopathy × Name Full Name ADRB1 adrenoceptor beta 1	Norepinephrine bitartrate 💬 Dilated cardiomyopathy × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 51. Dilated cardiomyopathy × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
53	Dilated cardiomyopathy 💬	[1] ADRB1 💬 Dilated cardiomyopathy × Name Full Name ADRB1 adrenoceptor beta 1	Norepinephrine hydrochoride 💬 Dilated cardiomyopathy × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 51. Dilated cardiomyopathy × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
54	Dilated cardiomyopathy 💬	[1] ADRB1 💬 Dilated cardiomyopathy × Name Full Name ADRB1 adrenoceptor beta 1	Propranolol hydrochloride 💬 Dilated cardiomyopathy × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 54. Dilated cardiomyopathy × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
55	Dilated cardiomyopathy 💬	[1] ADRB1 💬 Dilated cardiomyopathy × Name Full Name ADRB1 adrenoceptor beta 1	Propranolol 💬 Dilated cardiomyopathy × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 54. Dilated cardiomyopathy × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
56	Efferocytosis 💬	[1] PTGS2 💬 Efferocytosis × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Efferocytosis × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 56. Efferocytosis × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
57	Fluid shear stress and atherosclerosis 💬	[1] KLHL19 💬 Fluid shear stress and atherosclerosis × Name Full Name KLHL19	Dimethyl fumarate 💬 Fluid shear stress and atherosclerosis × Name Other Names Dimethyl fumarate Dimethyl fumarate (JAN/USAN) Tecfidera (TN) TECFIDERA DIMETHYL FUMARATE	Dimethyl fumarate	[6] 13, 20, 49, 51, 86, 296 💬 57. Fluid shear stress and atherosclerosis × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH; 296 Biliary atresia;
58	GABAergic synapse 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 GABAergic synapse × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Propofol 💬 GABAergic synapse × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 58. GABAergic synapse × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
59	Gap junction 💬	[1] ADRB1 💬 Gap junction × Name Full Name ADRB1 adrenoceptor beta 1	Noradrenaline 💬 Gap junction × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 59. Gap junction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
60	Gap junction 💬	[1] ADRB1 💬 Gap junction × Name Full Name ADRB1 adrenoceptor beta 1	Norepinephrine bitartrate 💬 Gap junction × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 59. Gap junction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
61	Gap junction 💬	[1] ADRB1 💬 Gap junction × Name Full Name ADRB1 adrenoceptor beta 1	Norepinephrine hydrochoride 💬 Gap junction × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 59. Gap junction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
62	Gap junction 💬	[1] ADRB1 💬 Gap junction × Name Full Name ADRB1 adrenoceptor beta 1	Propranolol hydrochloride 💬 Gap junction × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 62. Gap junction × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
63	Gap junction 💬	[1] ADRB1 💬 Gap junction × Name Full Name ADRB1 adrenoceptor beta 1	Propranolol 💬 Gap junction × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 62. Gap junction × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
64	Gastric acid secretion 💬	[1] CHRM3 💬 Gastric acid secretion × Name Full Name CHRM3 cholinergic receptor muscarinic 3	Rocuronium bromide 💬 Gastric acid secretion × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 64. Gastric acid secretion × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
65	Glucagon signaling pathway 💬	[1] NR1C1 💬 Glucagon signaling pathway × Name Full Name NR1C1	Bezafibrate 💬 Glucagon signaling pathway × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 65. Glucagon signaling pathway × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
66	Hematopoietic cell lineage 💬	[1] CSF3R 💬 Hematopoietic cell lineage × Name Full Name CSF3R colony stimulating factor 3 receptor	Filgrastim 💬 Hematopoietic cell lineage × Name Other Names Filgrastim Filgrastim (USP/INN) Filgrastim (genetical recombination) (JP18) Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN) Tbo-filgrastim Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN) Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN) Filgrastim-sndz Filgrastim-aafi Neupogen (TN) Nivestym (TN) Grastofil (TN) Zarxio (TN) GRANIX NEUPOGEN NIVESTYM NYPOZI RELEUKO ZARXIO	Filgrastim	[29]  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 66. Hematopoietic cell lineage × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 47 Buerger disease;Thromboangiitis obliterans; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 256 Muscle glycogenosis;Muscular glycogenosis;Muscle glycogen storage disease;Muscular glycogen storage disease;Glycogen storage disease type 0;GSD0;Glycogen synthase deficiency;Glycogen storage disease type II;GSDII;Pompe disease;Alpha-1,4-glucosidase acid deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Glycogen storage disease type V;GSDV;McArdle disease;Muscle phosphorylase deficiency;Muscular phosphorylase deficiency;Glycogen storage disease type VII;GSDVII;Tarui disease;Phosphofructokinase deficiency;PFK deficiency;Glycogen storage disease type IXd;GSDIXd;Phosphorylase kinase deficiency;Phosphoglycerate kinase deficiency;PGK deficiency;Glycogen storage disease type X;GSDX;Phosphoglycerate mutase deficiency;Glycogen storage diseass type XI;GSDXI;Kanno disease;Lactate dehydrogenase deficiency;Glycogen storage diseass type XII;GSDXII;Aldolase A deficiency;Glycogen storage diseass type XIII;GSDXIII;Beta-enolase deficiency;Glycogen storage diseass type XIV;GSDXIV;Phosphoglucomutase deficiency;Glycogen storage diseass type XV;GSDXV;Glycogenin 1 deficiency; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
67	Hematopoietic cell lineage 💬	[1] MS4A1 💬 Hematopoietic cell lineage × Name Full Name MS4A1 membrane spanning 4-domains A1	Rituximab 💬 Hematopoietic cell lineage × Name Other Names Rituximab Rituximab (USAN/INN) Rituximab (genetical recombination) (JAN) Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN) Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN) Rituximab-abbs Rituximab-pvvr Rituximab-arrx Rituxan (TN) Riabni (TN) Truximab (TN) RIABNI RITUXAN RUXIENCE TRUXIMA	Rituximab	[52] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 67. Hematopoietic cell lineage × Disease ID Name 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 35 Pemphigus; 36 Epidermolysis bullosa;Kindler syndrome; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 43 Microscopic polyangiitis;MPA; 44 Wegener granulomatosis;Multiple vasculitis granulomatous disease;Granulomatosis with polyangiitis; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 50 Dermatomyositis;Polymyositis; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 52 Mixed connective tissue disease; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 55 Relapsing polychondritis; 56 Behcet disease;Behçet disease;BD; 60 Aplastic anemia; 61 Autoimmune hemolytic anemia;AIHA;Cold agglutinin disease;CAD;Paroxysmal cold hemoglobinuria;Evans syndrome; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 83 Addison disease;Primary chronic adrenocortical insufficiency; 84 Sarcoidosis; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 162 Pemphigoid; 172 Hypophosphatasia; 220 Rapidly progressive glomerulonephritis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 229 Autoimmune pulmonary alveolar proteinosis;Congenital pulmonary alveolar proteinosis;Hereditary pulmonary alveolar proteinosis;Pulmonary alveolar proteinosis;PAP;Alveolar proteinosis; 256 Muscle glycogenosis;Muscular glycogenosis;Muscle glycogen storage disease;Muscular glycogen storage disease;Glycogen storage disease type 0;GSD0;Glycogen synthase deficiency;Glycogen storage disease type II;GSDII;Pompe disease;Alpha-1,4-glucosidase acid deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Glycogen storage disease type V;GSDV;McArdle disease;Muscle phosphorylase deficiency;Muscular phosphorylase deficiency;Glycogen storage disease type VII;GSDVII;Tarui disease;Phosphofructokinase deficiency;PFK deficiency;Glycogen storage disease type IXd;GSDIXd;Phosphorylase kinase deficiency;Phosphoglycerate kinase deficiency;PGK deficiency;Glycogen storage disease type X;GSDX;Phosphoglycerate mutase deficiency;Glycogen storage diseass type XI;GSDXI;Kanno disease;Lactate dehydrogenase deficiency;Glycogen storage diseass type XII;GSDXII;Aldolase A deficiency;Glycogen storage diseass type XIII;GSDXIII;Beta-enolase deficiency;Glycogen storage diseass type XIV;GSDXIV;Phosphoglucomutase deficiency;Glycogen storage diseass type XV;GSDXV;Glycogenin 1 deficiency; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 274 Osteogenesis Imperfecta; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 288 Autoimmune acquired coagulation factor deficiency;Coagulation factor deficiency;Factor XIII deficiency;Factor VIII deficiency;Acquired hemophilia A;VWF deficiency;von Willebrand Disease;VWD;Factor V deficiency;Factor X deficiency; 296 Biliary atresia; 300 IgG4-related disease;IgG4-related disease;Autoimmune pancreatitis;IgG4-related sclerosing cholangitis;IgG4-related lacrimal gland, orbital, and salivary gland lesions;IgG4-related kidney disease; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
68	Hepatitis B 💬	[1] SLC10A1 💬 Hepatitis B × Name Full Name SLC10A1 solute carrier family 10 member 1	Maralixibat 💬 Hepatitis B × Name Other Names Maralixibat Maralixibat (USAN)	Maralixibat	[4] 296, 297, 299, 338 💬 68. Hepatitis B × Disease ID Name 296 Biliary atresia; 297 Alagille syndrome; 299 Cystic fibrosis;CF; 338 Progressive familial intrahepatic cholestasis;PFIC;
69	Hepatitis C 💬	[1] NR1C1 💬 Hepatitis C × Name Full Name NR1C1	Bezafibrate 💬 Hepatitis C × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 69. Hepatitis C × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
70	Hepatocellular carcinoma 💬	[1] KLHL19 💬 Hepatocellular carcinoma × Name Full Name KLHL19	Dimethyl fumarate 💬 Hepatocellular carcinoma × Name Other Names Dimethyl fumarate Dimethyl fumarate (JAN/USAN) Tecfidera (TN) TECFIDERA DIMETHYL FUMARATE	Dimethyl fumarate	[6] 13, 20, 49, 51, 86, 296 💬 70. Hepatocellular carcinoma × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH; 296 Biliary atresia;
71	Hormone signaling 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 Hormone signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Hormone signaling × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 71. Hormone signaling × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
72	Hormone signaling 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 Hormone signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Hormone signaling × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 71. Hormone signaling × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
73	Hormone signaling 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 Hormone signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Hormone signaling × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 71. Hormone signaling × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
74	Hormone signaling 💬	[3] ADRB1, ADRB2, ADRB3 💬 Hormone signaling × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Hormone signaling × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 74. Hormone signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
75	Hormone signaling 💬	[3] ADRB1, ADRB2, ADRB3 💬 Hormone signaling × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Hormone signaling × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 74. Hormone signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
76	Human cytomegalovirus infection 💬	[1] PTGS2 💬 Human cytomegalovirus infection × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Human cytomegalovirus infection × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 76. Human cytomegalovirus infection × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
77	Human papillomavirus infection 💬	[1] PTGS2 💬 Human papillomavirus infection × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Human papillomavirus infection × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 77. Human papillomavirus infection × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
78	IL-17 signaling pathway 💬	[1] PTGS2 💬 IL-17 signaling pathway × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 IL-17 signaling pathway × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 78. IL-17 signaling pathway × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
79	Insulin resistance 💬	[1] NR1C1 💬 Insulin resistance × Name Full Name NR1C1	Bezafibrate 💬 Insulin resistance × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 79. Insulin resistance × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
80	Insulin secretion 💬	[1] CHRM3 💬 Insulin secretion × Name Full Name CHRM3 cholinergic receptor muscarinic 3	Rocuronium bromide 💬 Insulin secretion × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 80. Insulin secretion × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
81	Intestinal immune network for IgA production 💬	[1] TNFSF13B 💬 Intestinal immune network for IgA production × Name Full Name TNFSF13B TNF superfamily member 13b	Belimumab 💬 Intestinal immune network for IgA production × Name Other Names Belimumab Belimumab (USAN) Belimumab (genetical recombination) (JAN) Benlysta (TN) LymphoStat-B (TN) BENLYSTA	Belimumab	[14] 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬 81. Intestinal immune network for IgA production × Disease ID Name 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 43 Microscopic polyangiitis;MPA; 44 Wegener granulomatosis;Multiple vasculitis granulomatous disease;Granulomatosis with polyangiitis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 48 Primary antiphospholipid syndrome;Primary antiphospholipid antibody syndrome;Primary APS;PAPS; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 95 Autoimmune hepatitis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 296 Biliary atresia;
82	JAK-STAT signaling pathway 💬	[1] CSF3R 💬 JAK-STAT signaling pathway × Name Full Name CSF3R colony stimulating factor 3 receptor	Filgrastim 💬 JAK-STAT signaling pathway × Name Other Names Filgrastim Filgrastim (USP/INN) Filgrastim (genetical recombination) (JP18) Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN) Tbo-filgrastim Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN) Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN) Filgrastim-sndz Filgrastim-aafi Neupogen (TN) Nivestym (TN) Grastofil (TN) Zarxio (TN) GRANIX NEUPOGEN NIVESTYM NYPOZI RELEUKO ZARXIO	Filgrastim	[29]  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 82. JAK-STAT signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 47 Buerger disease;Thromboangiitis obliterans; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 256 Muscle glycogenosis;Muscular glycogenosis;Muscle glycogen storage disease;Muscular glycogen storage disease;Glycogen storage disease type 0;GSD0;Glycogen synthase deficiency;Glycogen storage disease type II;GSDII;Pompe disease;Alpha-1,4-glucosidase acid deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Glycogen storage disease type V;GSDV;McArdle disease;Muscle phosphorylase deficiency;Muscular phosphorylase deficiency;Glycogen storage disease type VII;GSDVII;Tarui disease;Phosphofructokinase deficiency;PFK deficiency;Glycogen storage disease type IXd;GSDIXd;Phosphorylase kinase deficiency;Phosphoglycerate kinase deficiency;PGK deficiency;Glycogen storage disease type X;GSDX;Phosphoglycerate mutase deficiency;Glycogen storage diseass type XI;GSDXI;Kanno disease;Lactate dehydrogenase deficiency;Glycogen storage diseass type XII;GSDXII;Aldolase A deficiency;Glycogen storage diseass type XIII;GSDXIII;Beta-enolase deficiency;Glycogen storage diseass type XIV;GSDXIV;Phosphoglucomutase deficiency;Glycogen storage diseass type XV;GSDXV;Glycogenin 1 deficiency; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
83	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬 Kaposi sarcoma-associated herpesvirus infection × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Kaposi sarcoma-associated herpesvirus infection × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 83. Kaposi sarcoma-associated herpesvirus infection × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
84	Leishmaniasis 💬	[1] PTGS2 💬 Leishmaniasis × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Leishmaniasis × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 84. Leishmaniasis × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
85	MicroRNAs in cancer 💬	[1] PTGS2 💬 MicroRNAs in cancer × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 MicroRNAs in cancer × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 85. MicroRNAs in cancer × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
86	Morphine addiction 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Morphine addiction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Propofol 💬 Morphine addiction × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 86. Morphine addiction × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
87	Neuroactive ligand signaling 💬	[8] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2 💬 Neuroactive ligand signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Noradrenaline 💬 Neuroactive ligand signaling × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 87. Neuroactive ligand signaling × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
88	Neuroactive ligand signaling 💬	[8] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2 💬 Neuroactive ligand signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Norepinephrine bitartrate 💬 Neuroactive ligand signaling × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 87. Neuroactive ligand signaling × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
89	Neuroactive ligand signaling 💬	[8] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2 💬 Neuroactive ligand signaling × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Norepinephrine hydrochoride 💬 Neuroactive ligand signaling × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 87. Neuroactive ligand signaling × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
90	Neuroactive ligand signaling 💬	[2] ADRB1, ADRB2 💬 Neuroactive ligand signaling × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Propranolol hydrochloride 💬 Neuroactive ligand signaling × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 90. Neuroactive ligand signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
91	Neuroactive ligand signaling 💬	[2] ADRB1, ADRB2 💬 Neuroactive ligand signaling × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2	Propranolol 💬 Neuroactive ligand signaling × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 90. Neuroactive ligand signaling × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
92	Neuroactive ligand signaling 💬	[11] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4 💬 Neuroactive ligand signaling × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2 CHRM3 cholinergic receptor muscarinic 3 CHRM4 cholinergic receptor muscarinic 4 CHRM5 cholinergic receptor muscarinic 5 CHRNA3 cholinergic receptor nicotinic alpha 3 subunit CHRNA4 cholinergic receptor nicotinic alpha 4 subunit CHRNA6 cholinergic receptor nicotinic alpha 6 subunit CHRNA7 cholinergic receptor nicotinic alpha 7 subunit CHRNB2 cholinergic receptor nicotinic beta 2 subunit CHRNB4 cholinergic receptor nicotinic beta 4 subunit	Rocuronium bromide 💬 Neuroactive ligand signaling × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 92. Neuroactive ligand signaling × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
93	Neuroactive ligand signaling 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Neuroactive ligand signaling × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Propofol 💬 Neuroactive ligand signaling × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 93. Neuroactive ligand signaling × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
94	Neuroactive ligand-receptor interaction 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Neuroactive ligand-receptor interaction × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 94. Neuroactive ligand-receptor interaction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
95	Neuroactive ligand-receptor interaction 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Neuroactive ligand-receptor interaction × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 94. Neuroactive ligand-receptor interaction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
96	Neuroactive ligand-receptor interaction 💬	[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRA2A adrenoceptor alpha 2A ADRA2B adrenoceptor alpha 2B ADRA2C adrenoceptor alpha 2C ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Neuroactive ligand-receptor interaction × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 94. Neuroactive ligand-receptor interaction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
97	Neuroactive ligand-receptor interaction 💬	[3] ADRB1, ADRB2, ADRB3 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Neuroactive ligand-receptor interaction × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 97. Neuroactive ligand-receptor interaction × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
98	Neuroactive ligand-receptor interaction 💬	[3] ADRB1, ADRB2, ADRB3 💬 Neuroactive ligand-receptor interaction × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Neuroactive ligand-receptor interaction × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 97. Neuroactive ligand-receptor interaction × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
99	Neuroactive ligand-receptor interaction 💬	[16] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4 💬 Neuroactive ligand-receptor interaction × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2 CHRM3 cholinergic receptor muscarinic 3 CHRM4 cholinergic receptor muscarinic 4 CHRM5 cholinergic receptor muscarinic 5 CHRNA10 cholinergic receptor nicotinic alpha 10 subunit CHRNA2 cholinergic receptor nicotinic alpha 2 subunit CHRNA3 cholinergic receptor nicotinic alpha 3 subunit CHRNA4 cholinergic receptor nicotinic alpha 4 subunit CHRNA5 cholinergic receptor nicotinic alpha 5 subunit CHRNA6 cholinergic receptor nicotinic alpha 6 subunit CHRNA7 cholinergic receptor nicotinic alpha 7 subunit CHRNA9 cholinergic receptor nicotinic alpha 9 subunit CHRNB2 cholinergic receptor nicotinic beta 2 subunit CHRNB3 cholinergic receptor nicotinic beta 3 subunit CHRNB4 cholinergic receptor nicotinic beta 4 subunit	Rocuronium bromide 💬 Neuroactive ligand-receptor interaction × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 99. Neuroactive ligand-receptor interaction × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
100	Neuroactive ligand-receptor interaction 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Neuroactive ligand-receptor interaction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Propofol 💬 Neuroactive ligand-receptor interaction × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 100. Neuroactive ligand-receptor interaction × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
101	Neuroactive ligand-receptor interaction 💬	[1] NR3C1 💬 Neuroactive ligand-receptor interaction × Name Full Name NR3C1 nuclear receptor subfamily 3 group C member 1	Dexamethasone 💬 Neuroactive ligand-receptor interaction × Name Other Names Dexamethasone Dexamethasone (JP18/USP/INN) Decadron (TN) Maxidex (TN) DEXTENZA HEMADY MAXIDEX OZURDEX DEXAMETHASONE DEXAMETHASONE INTENSOL TAPERDEX 12-DAY TAPERDEX 6-DAY	Dexamethasone	[25] 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬 101. Neuroactive ligand-receptor interaction × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 16 Crow-Fukase syndrome;Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome;POEMS syndrome;Takatsuki disease;Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome;PEP syndrome; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 35 Pemphigus; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 70 Spinal stenosis;Extensive spinal canal stenosis; 74 Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma; 75 Cushing disease;Cushing syndrome; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 90 Retinitis pigmentosa;Rod dystrophy;Cone-rod dystrophy;Rod-Cone Dystrophy; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 162 Pemphigoid; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 235 Hypoparathyroidism;Accessory thyroid hypergasia disease; 257 Hepatic glycogenosis;Liver glycogenosis;Hepatic glycogen storage disease;Liver glycogen storage disease;Glycogen storage disease type I;GSDI;von Gierke disease;Glucose-6-phosphatase deficiency;G6Pase deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type VI;GSDVI;Hers disease;Hepatic phosphorylase deficiency;Liver phosphorylase deficiency;Glycogen storage disease type IX;GSDIX;Phosphorylase kinase deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Adult polyglucosan body disease; 296 Biliary atresia; 299 Cystic fibrosis;CF; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
102	Neuroactive ligand-receptor interaction 💬	[1] NR3C1 💬 Neuroactive ligand-receptor interaction × Name Full Name NR3C1 nuclear receptor subfamily 3 group C member 1	Dexamethasone sodium phosphate 💬 Neuroactive ligand-receptor interaction × Name Other Names Dexamethasone sodium phosphate Dexamethasone sodium phosphate (JAN/USP) Dalalone (TN) Maxidex (TN)	Dexamethasone	[25] 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬 101. Neuroactive ligand-receptor interaction × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 16 Crow-Fukase syndrome;Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome;POEMS syndrome;Takatsuki disease;Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome;PEP syndrome; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 35 Pemphigus; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 70 Spinal stenosis;Extensive spinal canal stenosis; 74 Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma; 75 Cushing disease;Cushing syndrome; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 90 Retinitis pigmentosa;Rod dystrophy;Cone-rod dystrophy;Rod-Cone Dystrophy; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 162 Pemphigoid; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 235 Hypoparathyroidism;Accessory thyroid hypergasia disease; 257 Hepatic glycogenosis;Liver glycogenosis;Hepatic glycogen storage disease;Liver glycogen storage disease;Glycogen storage disease type I;GSDI;von Gierke disease;Glucose-6-phosphatase deficiency;G6Pase deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type VI;GSDVI;Hers disease;Hepatic phosphorylase deficiency;Liver phosphorylase deficiency;Glycogen storage disease type IX;GSDIX;Phosphorylase kinase deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Adult polyglucosan body disease; 296 Biliary atresia; 299 Cystic fibrosis;CF; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
103	Neuroactive ligand-receptor interaction 💬	[1] NR3C1 💬 Neuroactive ligand-receptor interaction × Name Full Name NR3C1 nuclear receptor subfamily 3 group C member 1	Dexamethasone phosphate 💬 Neuroactive ligand-receptor interaction × Name Other Names Dexamethasone phosphate Dexamethasone phosphate Decadron-phosphate (TN)	Dexamethasone	[25] 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬 101. Neuroactive ligand-receptor interaction × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 16 Crow-Fukase syndrome;Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome;POEMS syndrome;Takatsuki disease;Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome;PEP syndrome; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 35 Pemphigus; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 70 Spinal stenosis;Extensive spinal canal stenosis; 74 Prolactin secreting pituitary adenoma;Pituitary PRL secretion hyperthyroidism;Prolactinoma;Prolactin secreting adenoma; 75 Cushing disease;Cushing syndrome; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 90 Retinitis pigmentosa;Rod dystrophy;Cone-rod dystrophy;Rod-Cone Dystrophy; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 162 Pemphigoid; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 235 Hypoparathyroidism;Accessory thyroid hypergasia disease; 257 Hepatic glycogenosis;Liver glycogenosis;Hepatic glycogen storage disease;Liver glycogen storage disease;Glycogen storage disease type I;GSDI;von Gierke disease;Glucose-6-phosphatase deficiency;G6Pase deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type VI;GSDVI;Hers disease;Hepatic phosphorylase deficiency;Liver phosphorylase deficiency;Glycogen storage disease type IX;GSDIX;Phosphorylase kinase deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Adult polyglucosan body disease; 296 Biliary atresia; 299 Cystic fibrosis;CF; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
104	Neuroactive ligand-receptor interaction 💬	[1] NR3C1 💬 Neuroactive ligand-receptor interaction × Name Full Name NR3C1 nuclear receptor subfamily 3 group C member 1	Methylprednisolone 💬 Neuroactive ligand-receptor interaction × Name Other Names Methylprednisolone Methylprednisolone (JP18/USP/INN) Medrol (TN) MEDROL METHYLPREDNISOLONE	Methylprednisolone	[48]  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬 104. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 39 Toxic epidermal necrolysis;Toxic epidermal necrosis;TEN; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 43 Microscopic polyangiitis;MPA; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 50 Dermatomyositis;Polymyositis; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 83 Addison disease;Primary chronic adrenocortical insufficiency; 84 Sarcoidosis; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 162 Pemphigoid; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 211 Hypoplastic left heart syndrome;HLHS; 220 Rapidly progressive glomerulonephritis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 224 Purpura nephritis;Henoch-Schönlein purpura nephritis;HSPN; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 300 IgG4-related disease;IgG4-related disease;Autoimmune pancreatitis;IgG4-related sclerosing cholangitis;IgG4-related lacrimal gland, orbital, and salivary gland lesions;IgG4-related kidney disease;
105	Neuroactive ligand-receptor interaction 💬	[1] NR3C1 💬 Neuroactive ligand-receptor interaction × Name Full Name NR3C1 nuclear receptor subfamily 3 group C member 1	Methylprednisolone acetate 💬 Neuroactive ligand-receptor interaction × Name Other Names Methylprednisolone acetate Methylprednisolone acetate (JAN/USP) Depo-medrol (TN) DEPO-MEDROL METHYLPREDNISOLONE ACETATE	Methylprednisolone	[48]  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬 104. Neuroactive ligand-receptor interaction × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 19 Lysosomal storage disease;Lysosomal disease;Gaucher disease;Niemann-Pick disease type A/B;Niemann-Pick type A;NPD-A;NPA;Niemann-Pick type B;NPD-B;NPB;Acid sphingomyelinase deficiency;ASMD;Niemann-Pick disease type C;Niemann-Pick type C;NPD-C;NPC;GM1-gangliosidosis;GM1-gangliosidoses;GM2-gangliosidosis;GM2-gangliosidoses;Tay-Sachs disease;Sandhoff disease;Krabbe disease;Metachromatic leukodystrophy;MLD;Multiple-sulfatase deficiency;Farber disease;Mucopolysaccharidosis type I;Mucopolysaccharidosis I;MPS I;Hurler syndrome;Hurler-Scheie syndrome;Scheie syndrome;Mucopolysaccharidosis type II;Mucopolysaccharidosis II;MPS II;Hunter syndrome;Mucopolysaccharidosis type III;Mucopolysaccharidosis III;MPS III;Sanfilippo syndrome;Mucopolysaccharidosis type IV;Mucopolysaccharidosis IV;MPS IV;MPS IVA;Morquio syndrome;Morquio A syndrome;Mucopolysaccharidosis type VI;Mucopolysaccharidosis VI;MPS VI;Maroteaux-Lamy syndrome;Mucopolysaccharidosis type VII;Mucopolysaccharidosis VII;MPS VII;Sly syndrome;Mucopolysaccharidosis type IX;Mucopolysaccharidosis IX;MPS IX;Hyaluronidase deficiency;Sialidosis;Galactosialidosis;Mucolipidosis II;Mucolipidosis type II;I-cell disease;Mucolipidosis III;Mucolipidosis type III;Alpha-Mannosidosis;Alpha-Mannosidase Deficiency;Beta-Mannosidosis;Beta-Mannosidase Deficiency;Fucosidosis;Aspartylglucosaminuria;Schindler disease;Kanzaki disease;Pompe disease;Acid lipase deficiency;Wolman disease;Cholesterol ester storage disease;Danon disease;Free sialic acid storage disease;Infantile sialic acid storage disease;ISSD;Salla disease;Ceroid lipofuscinosis;Fabry disease;Cystinosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 39 Toxic epidermal necrolysis;Toxic epidermal necrosis;TEN; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 43 Microscopic polyangiitis;MPA; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 50 Dermatomyositis;Polymyositis; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 83 Addison disease;Primary chronic adrenocortical insufficiency; 84 Sarcoidosis; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 86 Pulmonary arterial hypertension;PAH; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 127 Frontotemporal lobar degeneration;Frontotemporal dementia, behavioral abnormal type;Frontotemporal dementia;Semantic dementia; 162 Pemphigoid; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 211 Hypoplastic left heart syndrome;HLHS; 220 Rapidly progressive glomerulonephritis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 224 Purpura nephritis;Henoch-Schönlein purpura nephritis;HSPN; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 300 IgG4-related disease;IgG4-related disease;Autoimmune pancreatitis;IgG4-related sclerosing cholangitis;IgG4-related lacrimal gland, orbital, and salivary gland lesions;IgG4-related kidney disease;
106	Neuroactive ligand-receptor interaction 💬	[1] NR3C1 💬 Neuroactive ligand-receptor interaction × Name Full Name NR3C1 nuclear receptor subfamily 3 group C member 1	Prednisolone 💬 Neuroactive ligand-receptor interaction × Name Other Names Prednisolone Prednisolone (JP18/USP/INN) Delta-cortef (TN)	Prednisolone	[41]  3 , 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 61, 63, 64, 66, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬 106. Neuroactive ligand-receptor interaction × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease; 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 14 Chronic inflammatory demyelinating polyneuropathy;Chronic inflammatory demyelinating poly (radiculo) neuropathy;CIDP;Multifocal motor neuropathy; 18 Spinocerebellar degeneration;SCD;:Spinocerebellar ataxia;SCA;Machado-Joseph disease;MJD;Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease;Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EAOH;Neu:Ataxia with vitamin E deficiency;AVED;Aprataxin deficiency;APTX deficiency;Friedreich ataxia;FRDA;Senataxin deficiency;SETX deficiency;Autosomal recessive spastic ataxia of Charlevoix-Saguenay;Spastic ataxia; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 39 Toxic epidermal necrolysis;Toxic epidermal necrosis;TEN; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 43 Microscopic polyangiitis;MPA; 44 Wegener granulomatosis;Multiple vasculitis granulomatous disease;Granulomatosis with polyangiitis; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 49 Systemic lupus erythematosus;SLE; 50 Dermatomyositis;Polymyositis; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 54 Adult still disease;Adult-onset Still's disease; 56 Behcet disease;Behçet disease;BD; 60 Aplastic anemia; 61 Autoimmune hemolytic anemia;AIHA;Cold agglutinin disease;CAD;Paroxysmal cold hemoglobinuria;Evans syndrome; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 64 Thrombotic thrombocytopenic purpura;TTP;Upshaw-Schulman syndrome;USS; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 81 Congenital adrenal hyperplasia;CAH;Congenital adrenal enzyme deficiency;Congenial adrenal cortex enzyme deficiency;Congenital Lipoid Adrenal Hyperplasia;3β-Hydroxysteroid Dehydrogenase Deficiency;21-Hydroxylase deficiency;21-OHD;11β-Hydroxylase deficiency;17α-Hydroxylase deficiency;P450 oxidoreductase deficiency; 84 Sarcoidosis; 85 Idiopathic interstitial pneumonia;IIPs;Idiopathic pulmonary fibrosis;IPF;Idiopathic non-specific interstitial pneumonia;Idiopathic NSIP;Respiratory bronchiolitis - associated interstitial lung disease;RB-ILD;Desquamative interstitial pneumonia;DIP;Cryptogenic organizing pneumonia;COP;Acute interstitial pneumonia;AIP;Idiopathic lymphocytic interstitial pneumonia;Idiopathic LIP;Idiopathic PPFE; 95 Autoimmune hepatitis; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 145 West syndrome;Infantile spasm;Infantile spasms;Infantile spasms syndrome;Infantile epileptic spasms;Infantile epileptic spasms syndrome; 162 Pemphigoid; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 251 Urea cycle disorder;N-acetylglutamate synthase deficiency;NAGS deficiency;Carbamoyl phosphate synthetase I deficiency;CPS1 deficiency;Ornithine transcarbamylase deficiency;OTC deficiency;Classic citrullinemia;Citrullinemia type I;Argininosuccinic aciduria;Argininemia;Hiperornitinemia-hiperamonemia-homocitrulinuria syndrome;HHH syndrome; 269 Pyogenic arthritis;Pyoderma gangrenosum;Acne syndrome;PAPA syndrome; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia; 299 Cystic fibrosis;CF; 300 IgG4-related disease;IgG4-related disease;Autoimmune pancreatitis;IgG4-related sclerosing cholangitis;IgG4-related lacrimal gland, orbital, and salivary gland lesions;IgG4-related kidney disease;
107	NF-kappa B signaling pathway 💬	[1] PTGS2 💬 NF-kappa B signaling pathway × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 NF-kappa B signaling pathway × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 107. NF-kappa B signaling pathway × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
108	NF-kappa B signaling pathway 💬	[1] TNFSF13B 💬 NF-kappa B signaling pathway × Name Full Name TNFSF13B TNF superfamily member 13b	Belimumab 💬 NF-kappa B signaling pathway × Name Other Names Belimumab Belimumab (USAN) Belimumab (genetical recombination) (JAN) Benlysta (TN) LymphoStat-B (TN) BENLYSTA	Belimumab	[14] 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬 108. NF-kappa B signaling pathway × Disease ID Name 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 43 Microscopic polyangiitis;MPA; 44 Wegener granulomatosis;Multiple vasculitis granulomatous disease;Granulomatosis with polyangiitis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 48 Primary antiphospholipid syndrome;Primary antiphospholipid antibody syndrome;Primary APS;PAPS; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 95 Autoimmune hepatitis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 296 Biliary atresia;
109	Nicotine addiction 💬	[4] CHRNA4, CHRNA6, CHRNA7, CHRNB2 💬 Nicotine addiction × Name Full Name CHRNA4 cholinergic receptor nicotinic alpha 4 subunit CHRNA6 cholinergic receptor nicotinic alpha 6 subunit CHRNA7 cholinergic receptor nicotinic alpha 7 subunit CHRNB2 cholinergic receptor nicotinic beta 2 subunit	Rocuronium bromide 💬 Nicotine addiction × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 109. Nicotine addiction × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
110	Nicotine addiction 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Nicotine addiction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Propofol 💬 Nicotine addiction × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 110. Nicotine addiction × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
111	Non-alcoholic fatty liver disease 💬	[1] NR1C1 💬 Non-alcoholic fatty liver disease × Name Full Name NR1C1	Bezafibrate 💬 Non-alcoholic fatty liver disease × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 111. Non-alcoholic fatty liver disease × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
112	Ovarian steroidogenesis 💬	[1] PTGS2 💬 Ovarian steroidogenesis × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Ovarian steroidogenesis × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 112. Ovarian steroidogenesis × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
113	Oxytocin signaling pathway 💬	[1] PTGS2 💬 Oxytocin signaling pathway × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Oxytocin signaling pathway × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 113. Oxytocin signaling pathway × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
114	Pancreatic secretion 💬	[1] CHRM3 💬 Pancreatic secretion × Name Full Name CHRM3 cholinergic receptor muscarinic 3	Rocuronium bromide 💬 Pancreatic secretion × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 114. Pancreatic secretion × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
115	Parkinson disease 💬	[1] KLHL19 💬 Parkinson disease × Name Full Name KLHL19	Dimethyl fumarate 💬 Parkinson disease × Name Other Names Dimethyl fumarate Dimethyl fumarate (JAN/USAN) Tecfidera (TN) TECFIDERA DIMETHYL FUMARATE	Dimethyl fumarate	[6] 13, 20, 49, 51, 86, 296 💬 115. Parkinson disease × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH; 296 Biliary atresia;
116	Pathways in cancer 💬	[1] CSF3R 💬 Pathways in cancer × Name Full Name CSF3R colony stimulating factor 3 receptor	Filgrastim 💬 Pathways in cancer × Name Other Names Filgrastim Filgrastim (USP/INN) Filgrastim (genetical recombination) (JP18) Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN) Tbo-filgrastim Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN) Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN) Filgrastim-sndz Filgrastim-aafi Neupogen (TN) Nivestym (TN) Grastofil (TN) Zarxio (TN) GRANIX NEUPOGEN NIVESTYM NYPOZI RELEUKO ZARXIO	Filgrastim	[29]  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 116. Pathways in cancer × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 47 Buerger disease;Thromboangiitis obliterans; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 256 Muscle glycogenosis;Muscular glycogenosis;Muscle glycogen storage disease;Muscular glycogen storage disease;Glycogen storage disease type 0;GSD0;Glycogen synthase deficiency;Glycogen storage disease type II;GSDII;Pompe disease;Alpha-1,4-glucosidase acid deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Glycogen storage disease type V;GSDV;McArdle disease;Muscle phosphorylase deficiency;Muscular phosphorylase deficiency;Glycogen storage disease type VII;GSDVII;Tarui disease;Phosphofructokinase deficiency;PFK deficiency;Glycogen storage disease type IXd;GSDIXd;Phosphorylase kinase deficiency;Phosphoglycerate kinase deficiency;PGK deficiency;Glycogen storage disease type X;GSDX;Phosphoglycerate mutase deficiency;Glycogen storage diseass type XI;GSDXI;Kanno disease;Lactate dehydrogenase deficiency;Glycogen storage diseass type XII;GSDXII;Aldolase A deficiency;Glycogen storage diseass type XIII;GSDXIII;Beta-enolase deficiency;Glycogen storage diseass type XIV;GSDXIV;Phosphoglucomutase deficiency;Glycogen storage diseass type XV;GSDXV;Glycogenin 1 deficiency; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
117	Pathways in cancer 💬	[1] KLHL19 💬 Pathways in cancer × Name Full Name KLHL19	Dimethyl fumarate 💬 Pathways in cancer × Name Other Names Dimethyl fumarate Dimethyl fumarate (JAN/USAN) Tecfidera (TN) TECFIDERA DIMETHYL FUMARATE	Dimethyl fumarate	[6] 13, 20, 49, 51, 86, 296 💬 117. Pathways in cancer × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH; 296 Biliary atresia;
118	Pathways in cancer 💬	[1] PTGS2 💬 Pathways in cancer × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Pathways in cancer × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 118. Pathways in cancer × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
119	Pathways of neurodegeneration - multiple diseases 💬	[4] CHRM1, CHRM3, CHRM5, CHRNA7 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM3 cholinergic receptor muscarinic 3 CHRM5 cholinergic receptor muscarinic 5 CHRNA7 cholinergic receptor nicotinic alpha 7 subunit	Rocuronium bromide 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 119. Pathways of neurodegeneration - multiple diseases × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
120	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬 Pathways of neurodegeneration - multiple diseases × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Pathways of neurodegeneration - multiple diseases × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 120. Pathways of neurodegeneration - multiple diseases × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
121	PI3K-Akt signaling pathway 💬	[2] CHRM1, CHRM2 💬 PI3K-Akt signaling pathway × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2	Rocuronium bromide 💬 PI3K-Akt signaling pathway × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 121. PI3K-Akt signaling pathway × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
122	PI3K-Akt signaling pathway 💬	[1] CSF3R 💬 PI3K-Akt signaling pathway × Name Full Name CSF3R colony stimulating factor 3 receptor	Filgrastim 💬 PI3K-Akt signaling pathway × Name Other Names Filgrastim Filgrastim (USP/INN) Filgrastim (genetical recombination) (JP18) Filgrastim (genetical recombination) [Filgrastim biosimilar 1] (JAN) Tbo-filgrastim Filgrastim (genetical recombination) [Filgrastim biosimilar 2] (JAN) Filgrastim (genetical recombination) [Filgrastim biosimilar 3] (JAN) Filgrastim-sndz Filgrastim-aafi Neupogen (TN) Nivestym (TN) Grastofil (TN) Zarxio (TN) GRANIX NEUPOGEN NIVESTYM NYPOZI RELEUKO ZARXIO	Filgrastim	[29]  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 122. PI3K-Akt signaling pathway × Disease ID Name  2  Amyotrophic lateral sclerosis;ALS;  6  Parkinson disease;Disease Parkinson's; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 25 Progressive multifocal leukoencephalopathy;PML;Leukoencephalopathy, progressive multifocal; 26 HTLV-1-associated myelopathy;Tropical spastic paraparesis;HTLV-1;HTLV-I;HAM; 28 Systemic amyloidosis;Immunoglobulin light chain amyloidosis;Amyloid light-chain amyloidosis;AL amyloidosis;Immunoglobulin light chain amyloidosis;Immunoglobulin-related amyloidosis;Amyloid heavy-chain amyloidosis;Amyloid heavy-chain amyloidosis;AH amyloidosis;Systemic wild-type transthyretin amyloidosis;Senile systemic amyloidosis;SSA;Hereditary transthyretin amyloidosis;Familial amyloidosis;Familial amyloid polyneuropathy;FAP;Hereditary systemic amyloidosis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 35 Pemphigus; 38 Stevens-Johnson syndrome;SJS;Mucocutaneous ocular syndrome; 40 Takayasu arteritis;Aortitis syndrome;Pulseless disease;Aortitis syndrome; 41 Giant cell arteritis;Temporal arteritis; 42 Polyarteritis nodosa;PAN; 45 Eosinophilic granulomatosis with Polyangiitis;EGPA;Eosinophilic multiple vasculitis granulomatous disease;Allergic granulomatous angiitis;AGA;Churg-Strauss syndrome;CSS; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 47 Buerger disease;Thromboangiitis obliterans; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 60 Aplastic anemia; 62 Paroxysmal nocturnal hemoglobinuria;PNH; 65 Primary immunodeficiency;X-linked severe combined immunodeficiency;X-SCID;Reticular dysgenesis;Adenosine deaminase deficiency;Omenn syndrome;Purine nucleoside phosphorylase deficiency;CD8 deficiency;ZAP-70 deficiency;MHC class I deficiency;MHC class II deficiency;Other combined immunodeficiencies;Wiskott-Aldrich syndrome;WAS;Ataxia telangiectasia;Nijmegen breakage syndrome;Bloom syndrome;Immunodeficiency, centromere region instability, facial anomalies syndrome;ICF syndrome;PMS2 deficiency;Radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties syndrome;RIDDLE syndrome;Schimke syndrome;Netherton syndrome;Thymic hypoplasia;DiGeorge syndrome;22q11.2 deletion syndrome;Hyper-IgE syndrome;Hepatic venoocclusive immunodeficiency;Immunodeficiency with central hepatic vein atresia;Dyskeratosis congenita;X-linked agammaglobulinaemia;Common variable immunodeficiency;Hyper-IgM syndrome;Isolated IgG subclass deficiency;Selective IgA deficiency;Specific antibody production deficiency;Infant transient hypogammaglobulinemia;Other predominantly antibody deficiencies;Chédiak-Higashi syndrome;Chediak-Higashi syndrome;X-linked lymphoproliferative syndrome;SAP deficiency;SH2D1A/SLAM-associated protein deficiency;XIAP deficiency;X-linked inhibitor of apoptosis deficiency;Autoimmune lymphoproliferative syndrome;ALPS;Other diseases of immune dysregulation;Familial hemophagocytic syndrome;FHPS;Familial hemophagocytic lymphohistiocytosis;FHL;Perforin deficiency;Munc13-4 deficiency;Syntaxin 11 deficiency;Munc18-2 deficiency;Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy;APECED;Autoimmune polyglandular syndrome;APS;Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome;IPEX syndrome;CD25 deficiency;ITCH deficiency;Severe congenital neutropenia;Cyclic neutropenia;Other congenital defects of neutrophil function;p14 deficiency;Glycogen storage disease type Ib;Leukocyte adhesion deficiency;Shwachman-Diamond syndrome;Chronic granulomatous disease;Myeloperoxidase deficiency;Mendelian susceptibility to mycobacterial disease;MSMD;Other congenital defects of phagocyte function;Anhidrotic ectodermal dysplasia with immunodeficiency;EDA-ID;Interleukin-1 receptor-associated kinase-4 deficiency;IRAK4 deficiency;MyD88 deficiency;Chronic mucocutaneous candidiasis;Other defects in innate immunity;Warts, hypogammaglobulinemia, infections, myelokathexis syndrome;WHIM syndrome;Congenital complement deficiency;C1q deficiency;C1r deficiency;C1s deficiency;C2 deficiency;C3 deficiency;C4 deficiency;C5 deficiency;C6 deficiency;C7 deficiency;C8 deficiency;C9 deficiency;Hereditary angioedema;C1 inhibitor deficiency;Inherited deficiency of complement system;Factor D deficiency;Factor I deficiency;Factor H deficiency;Properdin deficiency;MASP1 deficiency;MASP2 deficiency;3MC syndrome;Immunodeficiency associated with FCN3 mutation;FCN3; 96 Crohn disease;CD;Terminal ileitis;Inflammatory bowel disease;IBD; 113 Muscular dystrophy;Dystrophinopathies;Duchenne muscular dystrophy;DMD;Becker muscular dystrophy;BMD;Limb-girdle muscular dystrophy;LGMD;Congenital muscular dystrophy;CMD;Fukuyama-type congenital muscular dystrophy;FCMD;Walker-Warburg syndrome;Muscle-eye-brain disease;α-dystroglycanopathy;Integrin α7 deficient CMD;CIntegrin α7 deficient ongenital muscular dystrophy;Merosin-deficient congenital muscular dystrophy;Ullrich congenital muscular dystrophy;Laminopathy;Rigid spine syndrome;Dynamin 2 deficient congenital muscular dystrophy;Telesonin-deficient congenital muscular dystrophy;Congenital muscular dystrophy with mitochondrial structural abnormalities;Facioscapulohumeral muscular dystrophy;FSMD;Myotonic dystrophy;Dystrophia myotonica;DM;Emery-Dreifuss muscular dystrophy;EDMD;Oculopharyngeal muscular dystrophy;OPMD;Myotilinopathy;Caveolinopathy;Limb gridle muscular dystrophy 1C;LGMD1C;Desminopathy;Sarcoglycanopathy; 164 Oculocutaneous albinism;Hermansky-Pudlak syndrome;HPS;Chediak-Higashi syndrome;Chédiak-Higashi syndrome;CHS;Griscelli syndrome; 256 Muscle glycogenosis;Muscular glycogenosis;Muscle glycogen storage disease;Muscular glycogen storage disease;Glycogen storage disease type 0;GSD0;Glycogen synthase deficiency;Glycogen storage disease type II;GSDII;Pompe disease;Alpha-1,4-glucosidase acid deficiency;Glycogen storage disease type III;GSDIII;Cori disease;Forbes disease;Glycogen debranching enzyme deficiency;Glycogen storage disease type IV;GSDIV;Andersen disease;Glycogen-branching enzyme deficiency;GBED;Glycogen storage disease type V;GSDV;McArdle disease;Muscle phosphorylase deficiency;Muscular phosphorylase deficiency;Glycogen storage disease type VII;GSDVII;Tarui disease;Phosphofructokinase deficiency;PFK deficiency;Glycogen storage disease type IXd;GSDIXd;Phosphorylase kinase deficiency;Phosphoglycerate kinase deficiency;PGK deficiency;Glycogen storage disease type X;GSDX;Phosphoglycerate mutase deficiency;Glycogen storage diseass type XI;GSDXI;Kanno disease;Lactate dehydrogenase deficiency;Glycogen storage diseass type XII;GSDXII;Aldolase A deficiency;Glycogen storage diseass type XIII;GSDXIII;Beta-enolase deficiency;Glycogen storage diseass type XIV;GSDXIV;Phosphoglucomutase deficiency;Glycogen storage diseass type XV;GSDXV;Glycogenin 1 deficiency; 283 Acquired pure red cell aplasia;Pure red cell aplasia; 284 Diamond-Blackfan anemia; 285 Fanconi anemia; 296 Biliary atresia; 331 Idiopathic multicentric castleman disease;iMCD;Castleman disease;
123	PPAR signaling pathway 💬	[1] NR1C1 💬 PPAR signaling pathway × Name Full Name NR1C1	Bezafibrate 💬 PPAR signaling pathway × Name Other Names Bezafibrate Bezafibrate (JP18/USAN/INN) Bezatol SR (TN)	Bezafibrate	[8] 20, 93, 94, 160, 296, 316, 324, 344 💬 123. PPAR signaling pathway × Disease ID Name 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 93 Primary biliary cholangitis;Primary biliary cirrhosis;PBC; 94 Primary sclerosing cholangitis;PSC; 160 Congenital ichthyosis;Keratinopathic ichthyosis;Epidermolytic ichthyosis;Superficial epidermolytic ichthyosis;Harlequin ichthyosis;Autosomal recessive congenital ichthyosis;Congenital Ichthyosiform Erythroderma;Foliate ichthyosis;Ichthyosis syndrome;Netherton syndrome;Sjogren-Larsson syndrome;Sjögren-Larsson syndrome;Keratitis-ichtyosis-deafness syndrome;KID syndrome;Dorfman-Chanarin syndrome;Neutral lipid storage disease;NLSD;Multiple sulfatase deficiency;Austin disease;Recessive X-linked ichthyosis;RXLI;X-linked recessive ichthyosis;Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature;IBID;Trichothiodystrophy;Follicular ichthyosis;Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome;CHILD syndrome;Conradi-Hunermann-Happle syndrome;Conradi-Hünermann-Happle syndrome;CHHS; 296 Biliary atresia; 316 Carnitine cycle disorder;Carnitine palmitoyltransferase I deficiency;CPT1 deficiency;Carnitine palmitoyltransferase II deficiency;CPT2 deficiency;Carnitine-acylcarnitine translocase deficiency;CACT deficiency;Carnitine transporter deficiency;OCTN-2 deficiency; 324 Methylglutaconic aciduria;3-methylglutaconyl-CoA hydratase deficiency;3-methylglutaconic aciduria;3-MGA;3-MGA type I;Barth syndrome;3-MGA type II;Costeff syndrome;3-MGA type III; 344 Very long-chain acyl-CoA dehydrogenase deficiency;Very long-chain acyl-coenzyme A dehydrogenase deficiency;Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency;VLCAD deficiency;VLCADD;
124	Regulation of actin cytoskeleton 💬	[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Regulation of actin cytoskeleton × Name Full Name CHRM1 cholinergic receptor muscarinic 1 CHRM2 cholinergic receptor muscarinic 2 CHRM3 cholinergic receptor muscarinic 3 CHRM4 cholinergic receptor muscarinic 4 CHRM5 cholinergic receptor muscarinic 5	Rocuronium bromide 💬 Regulation of actin cytoskeleton × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 124. Regulation of actin cytoskeleton × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
125	Regulation of lipolysis in adipocytes 💬	[3] ADRB1, ADRB2, ADRB3 💬 Regulation of lipolysis in adipocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Regulation of lipolysis in adipocytes × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 125. Regulation of lipolysis in adipocytes × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
126	Regulation of lipolysis in adipocytes 💬	[3] ADRB1, ADRB2, ADRB3 💬 Regulation of lipolysis in adipocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Regulation of lipolysis in adipocytes × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 125. Regulation of lipolysis in adipocytes × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
127	Regulation of lipolysis in adipocytes 💬	[3] ADRB1, ADRB2, ADRB3 💬 Regulation of lipolysis in adipocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Regulation of lipolysis in adipocytes × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 125. Regulation of lipolysis in adipocytes × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
128	Regulation of lipolysis in adipocytes 💬	[3] ADRB1, ADRB2, ADRB3 💬 Regulation of lipolysis in adipocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Regulation of lipolysis in adipocytes × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 128. Regulation of lipolysis in adipocytes × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
129	Regulation of lipolysis in adipocytes 💬	[3] ADRB1, ADRB2, ADRB3 💬 Regulation of lipolysis in adipocytes × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Regulation of lipolysis in adipocytes × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 128. Regulation of lipolysis in adipocytes × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
130	Regulation of lipolysis in adipocytes 💬	[1] PTGS2 💬 Regulation of lipolysis in adipocytes × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Regulation of lipolysis in adipocytes × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 130. Regulation of lipolysis in adipocytes × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
131	Renin secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Renin secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Renin secretion × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 131. Renin secretion × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
132	Renin secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Renin secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Renin secretion × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 131. Renin secretion × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
133	Renin secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Renin secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Renin secretion × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 131. Renin secretion × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
134	Renin secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Renin secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Renin secretion × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 134. Renin secretion × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
135	Renin secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Renin secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Renin secretion × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 134. Renin secretion × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
136	Retrograde endocannabinoid signaling 💬	[16] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Retrograde endocannabinoid signaling × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA GABRB GABRB GABRB GABRD gamma-aminobutyric acid type A receptor subunit delta GABRE gamma-aminobutyric acid type A receptor subunit epsilon GABRG GABRG GABRG GABRP gamma-aminobutyric acid type A receptor subunit pi GABRQ gamma-aminobutyric acid type A receptor subunit theta	Propofol 💬 Retrograde endocannabinoid signaling × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 136. Retrograde endocannabinoid signaling × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
137	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬 Retrograde endocannabinoid signaling × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Retrograde endocannabinoid signaling × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 137. Retrograde endocannabinoid signaling × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
138	Rheumatoid arthritis 💬	[1] TNFSF13B 💬 Rheumatoid arthritis × Name Full Name TNFSF13B TNF superfamily member 13b	Belimumab 💬 Rheumatoid arthritis × Name Other Names Belimumab Belimumab (USAN) Belimumab (genetical recombination) (JAN) Benlysta (TN) LymphoStat-B (TN) BENLYSTA	Belimumab	[14] 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬 138. Rheumatoid arthritis × Disease ID Name 11 Myasthenia gravis;MG; 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 43 Microscopic polyangiitis;MPA; 44 Wegener granulomatosis;Multiple vasculitis granulomatous disease;Granulomatosis with polyangiitis; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 48 Primary antiphospholipid syndrome;Primary antiphospholipid antibody syndrome;Primary APS;PAPS; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 53 Sjogren syndrome;Sjögren syndrome;Syndrome Sjogren's;Autoimmune exocrinopathy; 63 Idiopathic thrombocytopenic purpura;Primary immune thrombocytopenia;Immune thrombocytopenic purpura; 66 IgA nephropathy;IgA nephritis;Berger disease;IgA-IgG nephropathy; 95 Autoimmune hepatitis; 222 Primary nephrotic syndrome;Minimal change nephrotic syndrome;MCNS;Membranous nephropathy;Focal segmental glomerulosclerosis;FSGS;Membranoproliferative glomerulonephritis;MPGN; 296 Biliary atresia;
139	Salivary secretion 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 Salivary secretion × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Salivary secretion × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 139. Salivary secretion × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
140	Salivary secretion 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 Salivary secretion × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Salivary secretion × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 139. Salivary secretion × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
141	Salivary secretion 💬	[6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 💬 Salivary secretion × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Salivary secretion × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 139. Salivary secretion × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
142	Salivary secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Salivary secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Salivary secretion × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 142. Salivary secretion × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
143	Salivary secretion 💬	[3] ADRB1, ADRB2, ADRB3 💬 Salivary secretion × Name Full Name ADRB1 adrenoceptor beta 1 ADRB2 adrenoceptor beta 2 ADRB3 adrenoceptor beta 3	Propranolol 💬 Salivary secretion × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 142. Salivary secretion × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
144	Salivary secretion 💬	[1] CHRM3 💬 Salivary secretion × Name Full Name CHRM3 cholinergic receptor muscarinic 3	Rocuronium bromide 💬 Salivary secretion × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 144. Salivary secretion × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
145	Serotonergic synapse 💬	[3] GABRB, GABRB, GABRB 💬 Serotonergic synapse × Name Full Name GABRB GABRB GABRB	Propofol 💬 Serotonergic synapse × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 145. Serotonergic synapse × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
146	Serotonergic synapse 💬	[1] PTGS2 💬 Serotonergic synapse × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Serotonergic synapse × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 146. Serotonergic synapse × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
147	Small cell lung cancer 💬	[1] PTGS2 💬 Small cell lung cancer × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 Small cell lung cancer × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 147. Small cell lung cancer × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
148	Taste transduction 💬	[1] CHRM3 💬 Taste transduction × Name Full Name CHRM3 cholinergic receptor muscarinic 3	Rocuronium bromide 💬 Taste transduction × Name Other Names Rocuronium bromide Rocuronium bromide (JAN/USP/INN) Zemuron (TN)	Rocuronium	[2] 70, 296 💬 148. Taste transduction × Disease ID Name 70 Spinal stenosis;Extensive spinal canal stenosis; 296 Biliary atresia;
149	Taste transduction 💬	[6] GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Taste transduction × Name Full Name GABRA GABRA GABRA GABRA GABRA GABRA	Propofol 💬 Taste transduction × Name Other Names Propofol Propofol (JAN/USP/INN) Diprivan (TN) DIPRIVAN PROPOFOL PROPOFOL INJECTABLE EMULSION	Propofol	[10]  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬 149. Taste transduction × Disease ID Name  3  Spinal muscular atrophy;SMA;Myelopathic muscular atrophy;Werdnig-Hoffman disease;Dubowitz disease;Kugelberg-Welander disease;  6  Parkinson disease;Disease Parkinson's; 21 Mitochondrial disease;Choronic progressive external ophthalmolegia;CPEO;Leigh syndrome;Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episode;MELAS;Myoclonus epilepsy associated with ragged-red fibers;MERRF;Mitochondrial respiratory chain disorders;Pearson syndrome; 22 Moyamoya disease;Occlusive disease in circle of Willis; 34 Neurofibromatosis;Neurofibromatosis type 1;NF1;Recklinghausen disease;Neurofibromatosis type 2;NF2; 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 70 Spinal stenosis;Extensive spinal canal stenosis; 97 Ulcerative colitis;UC;Inflammatory bowel disease;IBD; 98 Eosinophilic gastro-intestinal disorder;EGID;Eosinophilic gastrointestinal disease;Eosinophilic gastroenteritis;Eosinophilic esophagitis;Eosinophilic colitis;Neonatal food-protein induced enterocolitis syndrome;Neonatal food-protein induced enterocolitis;N-FPIES;Eosinophilic esophagitis;EoE;Eosinophilic gastroenteritis;EGE; 296 Biliary atresia;
150	Thermogenesis 💬	[1] ADRB3 💬 Thermogenesis × Name Full Name ADRB3 adrenoceptor beta 3	Noradrenaline 💬 Thermogenesis × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 150. Thermogenesis × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
151	Thermogenesis 💬	[1] ADRB3 💬 Thermogenesis × Name Full Name ADRB3 adrenoceptor beta 3	Norepinephrine bitartrate 💬 Thermogenesis × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 150. Thermogenesis × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
152	Thermogenesis 💬	[1] ADRB3 💬 Thermogenesis × Name Full Name ADRB3 adrenoceptor beta 3	Norepinephrine hydrochoride 💬 Thermogenesis × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 150. Thermogenesis × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
153	Thermogenesis 💬	[1] ADRB3 💬 Thermogenesis × Name Full Name ADRB3 adrenoceptor beta 3	Propranolol hydrochloride 💬 Thermogenesis × Name Other Names Propranolol hydrochloride Propranolol hydrochloride (JP18/USP) Inderal (TN) Innopran XL (TN) HEMANGEOL INDERAL INDERAL XL INNOPRAN XL PROPRANOLOL PROPRANOLOL HYDROCHLORIDE	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 153. Thermogenesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
154	Thermogenesis 💬	[1] ADRB3 💬 Thermogenesis × Name Full Name ADRB3 adrenoceptor beta 3	Propranolol 💬 Thermogenesis × Name Other Names Propranolol Propranolol (INN) Propranolol (TN)	Propranolol	[7]  6 , 158, 215, 216, 227, 278, 296 💬 153. Thermogenesis × Disease ID Name  6  Parkinson disease;Disease Parkinson's; 158 Tuberous sclerosis;Tuberous sclerosis complex;TSC; 215 Tetralogy of Fallot;Fallot tetralogy; 216 Double outlet right ventricle; 227 Osler disease;Hereditary hemorrhagic telangiectasia;HHT;Osler-Weber-Rendu disease; 278 Huge lymphatic malformation with cervicofacial lesion;Huge lymphatic malformation;Lymphatic malformation; 296 Biliary atresia;
155	TNF signaling pathway 💬	[1] PTGS2 💬 TNF signaling pathway × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 TNF signaling pathway × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 155. TNF signaling pathway × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
156	Ubiquitin mediated proteolysis 💬	[1] KLHL19 💬 Ubiquitin mediated proteolysis × Name Full Name KLHL19	Dimethyl fumarate 💬 Ubiquitin mediated proteolysis × Name Other Names Dimethyl fumarate Dimethyl fumarate (JAN/USAN) Tecfidera (TN) TECFIDERA DIMETHYL FUMARATE	Dimethyl fumarate	[6] 13, 20, 49, 51, 86, 296 💬 156. Ubiquitin mediated proteolysis × Disease ID Name 13 Multiple sclerosis;Neuromyelitis optica;Neuromyelitis optica spectrum disorder;NMOSD;Balo concentric sclerosis;Baló concentric sclerosis; 20 Adrenoleukodystrophy;ALD;Childhood cerebral ALD;CCALD;Adolescent cerebral ALD;AdoCALD;AdolCALD;Adrenomyeloneuropathy;AMN;Adult cerebral ALD;ACALD; 49 Systemic lupus erythematosus;SLE; 51 Scleroderma;Systemic sclerosis;SSc;Diffuse cutaneous SSc;dcSSc;Limited cutaneous SSc;lcSSc; 86 Pulmonary arterial hypertension;PAH; 296 Biliary atresia;
157	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Vascular smooth muscle contraction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Noradrenaline 💬 Vascular smooth muscle contraction × Name Other Names Noradrenaline Noradrenaline (JP18) Norepinephrine (INN) Nor adrenalin (TN)	Norepinephrine	[2] 22, 296 💬 157. Vascular smooth muscle contraction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
158	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Vascular smooth muscle contraction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Norepinephrine bitartrate 💬 Vascular smooth muscle contraction × Name Other Names Norepinephrine bitartrate Norepinephrine bitartrate (USP) Levophed (TN) LEVOPHED LEVOPHED(R) NOREPINEPHRINE BITARTRATE NOREPINEPHRINE NOREPINEPHRINE BITARTRATE NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE NOREPINEPHR BITART	Norepinephrine	[2] 22, 296 💬 157. Vascular smooth muscle contraction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
159	Vascular smooth muscle contraction 💬	[3] ADRA1A, ADRA1B, ADRA1D 💬 Vascular smooth muscle contraction × Name Full Name ADRA1A adrenoceptor alpha 1A ADRA1B adrenoceptor alpha 1B ADRA1D adrenoceptor alpha 1D	Norepinephrine hydrochoride 💬 Vascular smooth muscle contraction × Name Other Names Norepinephrine hydrochoride Norepinephrine hydrochoride (-)-Noradrenaline hydrochloride Arterenol (TN)	Norepinephrine	[2] 22, 296 💬 157. Vascular smooth muscle contraction × Disease ID Name 22 Moyamoya disease;Occlusive disease in circle of Willis; 296 Biliary atresia;
160	VEGF signaling pathway 💬	[1] PTGS2 💬 VEGF signaling pathway × Name Full Name PTGS2 prostaglandin-endoperoxide synthase 2	Meloxicam 💬 VEGF signaling pathway × Name Other Names Meloxicam Meloxicam (JAN/USP/INN) Mobic (TN) MELOXICAM	Meloxicam	[3] 46, 271, 296 💬 160. VEGF signaling pathway × Disease ID Name 46 Malignant rheumatoid arthritis;MRA;Rheumatoid vasculitis;RV;Rheumatoid arthritis;RA;Systemic rheumatoid vasculitis;SRV; 271 Ankylosing spondylitis;Spondylarthritis ankylopoietica; 296 Biliary atresia;
161	Virion - Hepatitis viruses 💬	[1] SLC10A1 💬 Virion - Hepatitis viruses × Name Full Name SLC10A1 solute carrier family 10 member 1	Maralixibat 💬 Virion - Hepatitis viruses × Name Other Names Maralixibat Maralixibat (USAN)	Maralixibat	[4] 296, 297, 299, 338 💬 161. Virion - Hepatitis viruses × Disease ID Name 296 Biliary atresia; 297 Alagille syndrome; 299 Cystic fibrosis;CF; 338 Progressive familial intrahepatic cholestasis;PFIC;

Back to top